NO LEGACY EFFECT OF SIX MONTHS' TREATMENT OF CILOSTAZOL ON THE LONG-TERM PROGNOSIS OF PATIENTS WHO UNDERWENT DRUG-ELUTING STENT IMPLANTATION: 2-YEAR FOLLOW-UP OF THE CILON-T TRIAL

NO LEGACY EFFECT OF SIX MONTHS' TREATMENT OF CILOSTAZOL ON THE LONG-TERM PROGNOSIS OF PATIENTS WHO UNDERWENT DRUG-ELUTING STENT IMPLANTATION: 2-YEAR FOLLOW-UP OF THE CILON-T TRIAL

Two-year ischemic events including cardiac death, non-fatal myocardial infarction, ischemic stroke and target lesion revascularization (TLR) were evaluated.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E1404-E1404
Hauptverfasser: Kim, Hack-Lyoung, Suh, Jung-Won, Lee, Seng-Pyo, Oh, Ii-Young, Kang, Hyun-Jae, Koo, Bon-Kwon, Cho, Young-Seok, Youn, Tae-Jin, Chae, In-Ho, Choi, Dong-Ju, Kwon, Taek-Geun, Bae, Jang-Ho, Rha, Seung-Woon, Bae, Jang-Whan, Cho, Myoung-Chan, Kim, Hyo-Soo
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Confidence intervals
Drug therapy
Heart attacks
Internal Medicine
Multivariate analysis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Two-year ischemic events including cardiac death, non-fatal myocardial infarction, ischemic stroke and target lesion revascularization (TLR) were evaluated.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(12)61405-3